Navigation Links
Analysis Of Human Genome To Predict The Development Of Illnesses

The GARBAN project, drawn up by Navarre University, will enable the identification of therapeutic targets for cancer, depression and hepatitis.

The School of Engineering at Navarre University and its Centre for Technical Studies and Research in Gipuzkoa (CEIT) have launched an advanced biochemical analysis tool that will help in predicting the evolution of diseases, accelerate their diagnosis and identify new therapeutic targets (lines of action) for ailments such as cancer, depression and hepatitis.

This bioinformatics tool, designed in collaboration with the Centre for Applied Research in Medicine (CIMA) at Navarre University and known as GARBAN (Genomic Analysis for Rapid Biological Annotation), carries out the following process: firstly, it hierarchically classifies all known genes and proteins according to their molecular function, molecular composition and biological process. With the unknown ones, they are logged (comparing similarities and differences with respect to these same molecules in other living things) and molecules with a similar sequence
to theirs are observed in order to deduce their function and to classify them in the same order as the molecules already known.

The project also includes all genes and proteins ordered according to their behaviour in determined circumstances. To this end, it compares the same genes and proteins amongst healthy and unwell persons and amongst ill persons receiving different treatment. In this way, the behaviour of these molecules at different moments in the illness is registered.

Available on Internet

Once the function and behaviour of the genes and proteins are registered, this analysis tool detects anomalous behaviour of these molecules that could give rise to an illness and presents all this graphically as a map and thus, the doctor can anticipate the development of the illness. If the ailment has already initiated, this system enables a visual graphical representation
'"/>

Source:Navarre University


Page: 1 2

Related biology news :

1. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
2. Eliminate Data Analysis Bottlenecks in Drug Discovery
3. Analysis of flower genes reveals the fate of an ancient gene duplication
4. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
5. Analysis of breast-cancer gene role offers promising target
6. Analysis of rhesus monkey genome uncovers genetic differences with humans, chimps
7. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
8. New Clues Add 40,000 Years to Age of Human Species
9. Human Cells Filmed Instantly Messaging for First Time
10. Govt Creates Gene Database of Normal Human Tissues
11. Human Eggs Can Develop From Ovarian Surface Cells In Vitro

Post Your Comments:
(Date:11/23/2009)..., Mass. November 23, 2009 Applied mathematicians...osta lancifolia ), a characteristic long leaf with...ipples along the edges. The simple cause of the li...om bending during differential growthwas revealed ...oam ribbons. , Haiyi Liang, a postdoctoral stude...
(Date:11/23/2009).... -- More than 160 participants gathered this week...TURES INITIATIVE conference. This year,s topic, "S...gineers, and medical researchers to explore the en...ng the emerging field of synthetic biology. , Bo... Princeton University and this year,s conference c...
(Date:11/23/2009)...- The only swine vaccine available for the H1N1 vi...ed with the virus. The vaccination marks the first...sed with the pandemic flu., Iowa State Universit...loped the vaccine this summer and has been shippin...sas and Illinois for several weeks., The latest ...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 1Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 3Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 1Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 2Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 1DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 4
...University at Buffalo and the University of Pennsy...acellular events, both stimulated by the same cell...als. , The broad implication of the findings may a...t sub-cellular underpinnings of mammalian behavior...vergent Behavioral Roles of Angiotensin Receptor I...
...k-footed geese (Anser brachyrhynchus) prepare for ...n the Arctic, ecologists are warning that the esca...hreatening the birds, survival. Writing in the new... of Applied Ecology, Professor Marcel Klaassen of ...ernational action is urgently required. , Farmers ...
...x linking artificial sweeteners such as saccharin ...es on a sweet taste has guided researchers to an i...taste. , Reporting in an advance online publicat... Senses Center describe how certain artificial swe...-K, paradoxically inhibit sweet taste at high conc...
Other Biology News:Manipulating single cell receptor alters animal behavior 2Manipulating single cell receptor alters animal behavior 3Spring migration of pink-footed geese under threat 2Sweet 'water taste' paradoxically predicts sweet taste inhibitors 2
(Date:11/24/2009)... Ambassador to also Visit Detroit...009 -- , , ,Who: David Appia, French Ambassador fo...f the Invest in France Agency, , , , ,What: Ambas...cuss recent pro-business initiatives adopted by Fr...academic landscape for innovation and development....
(Date:11/24/2009)...CALGARYandBLENHEIM,Ontario,Nov.24/PRNewswire-First...iringtheassetsofHylandSeeds,adivisionofThompsonsLi...llfurtherexpandDowAgroSciences,currentseedsbusines...x(TM) in 2010 andDowAgroSciencesHerbicideToleran...isexpectedinthenearfuture. ,, "Thisacquisitionb...
(Date:11/24/2009)... Health care employment grew by... only one to show consistent growth during the U.S...als remain in trouble, and health systems are comi...nel, instead of just administrators. , ...care employment continued growing in October despi...
(Date:11/24/2009)...SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neur...yfocusedondevelopingandcommercializingnovelpainman...PresidentandChiefExecutiveOfficer,isscheduledtopre...e,tobeheldDecember1-2,2009atTheNewYorkPalaceHoteli...eri,ChiefFinancialOfficer,willbeavailabletorespond...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3
...y announces implementation of Kingdee enterprise a...perations , , TUSTIN, Calif., Jan. 29 AMDL, Inc.... pharmaceutical company with operations in China a...ate-of-the-art, westernized enterprise accounting ..., , Developed by China-based Kingdee Internatio...
...ies to Collaborate on Next Generation Laboratory I...ss., Jan. 29 Cantimer, Inc. and Advanced Instrume...struments Inc. has made a $1 Million equity invest...nced their intention to collaborate on the develop... for osmolality measurement, incorporating Cantime...
...y will proceed with clinical trials of first-in-cl...SHORES, Calif., Jan. 29 Omnitura Therapeutics Inc... into a $24 million private placement agreement wi...ancing, investments will be made in three tranches...ore December 31, 2009 and $8 million before Decemb...
Other Biology Technology:AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 2AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 3AMDL First to Implement US & China-Based, GAAP-Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 4Advanced Instruments Makes Strategic Investment in Cantimer, Inc. 2Omnitura Therapeutics Announces Private Placement Financing 2
Anti-4-hydroxy-2-hexenal Monoclonal Antibody, Unconjugated from Cosmo Bio Co., Ltd.
Anti-Human VEGFR-2 / KDR Antibody, Unconjugated from Cell Sciences
Rabbit Anti-Human Tankyrase 2 (TNKL (TNKS2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
...olved in translation initiation. PHAS-II is highes...E, the mRNA cap-binding protein, and inhibit trans...horylation in the appropriate site(s) promotes dis...F-4E to bind to eIF-4G (p220), thereby increasing ...
Biology Products: